FDA Inspection 1007135 — New York Presbyterian Brooklyn Methodist Hospital IRB
The FDA completed an inspection of New York Presbyterian Brooklyn Methodist Hospital IRB on March 29, 2017 in Brooklyn, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 29, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Brooklyn, NY (United States)
Additional Details
IRB